RecruitingNot ApplicableNCT06905223
A Pilot Study of Synbiotics in Adults With Depressive Symptoms
A Pilot Study on the Efficacy of a Synbiotic Formula (MQU10) in Improving Mood and Well-being in Adults With Mild to Moderate Depressive Symptoms
Sponsor
GenieBiome Limited
Enrollment
30 participants
Start Date
Apr 3, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
This study aims to explore the efficacy and safety of a synbiotic formula (MQU10) in improving mood and well-being in adults with mild to moderate depressive symptoms.
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Individuals aged 18 or above
- Patient Health Questionnaire-9 (PHQ-9) score between 5 to 14
- Literate and can complete the self-report questionnaires
- Able to understand the consent and sign the informed consent form
Exclusion Criteria11
- Current diagnosis of substance abuse or dependence;
- A current or past history of bipolar disorder, manic or hypomanic episodes, schizophrenia, personality disorder, posttraumatic stress disorder (PTSD), intellectual disability, neurodegenerative disorders (e. g, Parkinson's disease) or organic mental disorder
- Requiring immediate psychiatric care (e. g, imminently suicidal subjects) or have attempted suicide in the past 3 months
- Use of antipsychotics, antidepressants or sedatives, unless on a stable dose in the last 4 weeks
- History of severe organ failure, renal failure on dialysis, HIV infection
- Active malignancy within 5 years
- History of major surgery on the gastrointestinal tract, except cholecystectomy and appendectomy in the past 5 years
- Night shift work
- History of antibiotic use within 4 weeks
- History of allergy to probiotics or lactose leading to a severe allergic reaction
- Known pregnancy or lactating
Interventions
DIETARY_SUPPLEMENTMQU10
MQU10 consists of a blend of food-grade probiotic strains (20 billion CFU daily) and prebiotic compounds.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06905223